Expression of CTRP3, a Novel Adipokine, in Rats at Different Pathogenic Stages of Type 2 Diabetes Mellitus and the Impacts of GLP-1 Receptor Agonist on It

Expression of CTRP3, a Novel Adipokine, in Rats at Different Pathogenic Stages of Type 2 Diabetes Mellitus and the Impacts of GLP-1 Receptor Agonist on It

Saved in:

Bibliographic Details
Main Authors:	Xin Li, Li Jiang, Miao Yang, Yu-wen Wu, Su-xin Sun, Jia-zhong Sun
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2014/398518
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adverse effects of GLP – 1 Receptor Agonists
by: Anna Kasprzak, et al.
Published: (2025-02-01)

The Effect of Intermittent High-Intensity and Continuous Moderate-Intensity Exercises on CTRP-1, CTRP-5 and CTRP-15 Values in Rats Fed with a High-Fat Diet
by: Mostafa Fahmi Alsediri, et al.
Published: (2024-12-01)

GLP-1 Receptor Agonists’ Impact on Fertility - A Review
by: Joanna Wojda, et al.
Published: (2025-02-01)

Effect of GLP-1 Receptor Agonists (Liraglutide) on Glycemic Parameters and Circulating miRNA Expression in Type 2 Diabetes Mellitus
by: Aqeel Meer AL-ZAMILY
Published: (2025-06-01)

A Comprehensive Review on the Pharmacokinetics and Drug&minus;Drug Interactions of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Agonist
by: Min JS, et al.
Published: (2025-04-01)

Advances in GLP-1 receptor agonists for pain treatment and their future potential
by: Yongtao He, et al.
Published: (2025-02-01)

GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
by: Giulia Migliorisi, et al.
Published: (2025-07-01)

GLP-1 receptor agonist therapy and pregnancy: Evolving and emerging evidence
by: Maria S Varughese, et al.
Published: (2025-03-01)

The hidden impact of GLP‐1 receptor agonists on endometrial receptivity and implantation
by: Alberto Sola‐Leyva, et al.
Published: (2025-02-01)

The new era of aspiration risk: The dilemma of GLP-1 receptor agonists
by: Jack Madden, et al.
Published: (2024-03-01)

Exploring the multifaceted roles of GLP-1 receptor agonists; a comprehensive review
by: Bisma Fatima Hammad, et al.
Published: (2025-07-01)

Improving Reproductive Outcomes in PCOS: The Emerging Role of GLP-1 Receptor Agonists
by: Adrianna Tabeau, et al.
Published: (2025-03-01)

Role of physical activity in GLP-1 receptor agonist therapy for obesity treatment
by: Łukasz Zdziebkowski, et al.
Published: (2025-07-01)

Impact of GLP-1 Receptor Agonists on Perceived Eating Behaviors in Response to Stimuli
by: Cheney C, et al.
Published: (2025-05-01)

Beyond Benefits: The Unseen Risks of GLP-1 Receptor Agonists in Recent Trials
by: Mahmoud H. Elbatreek
Published: (2024-12-01)

The Impact of GLP-1 Receptor Agonists on Women's Reproductive Health: A Review
by: Marta Wolszczak, et al.
Published: (2025-06-01)

Methodological considerations in assessing GLP-1 receptor agonists and gastrointestinal cancer risk
by: Cheng-Hsien Hung, et al.
Published: (2024-12-01)

Weight loss mediates improvement in proinsulin processing during GLP-1 receptor agonist treatment
by: Renjiao Liu, et al.
Published: (2025-07-01)

Evaluating video capsule endoscopy in diabetes mellitus: transit times, preparation adequacy, and the influence of insulin and GLP-1 receptor agonist use
by: Nimrod Akerman, et al.
Published: (2025-08-01)

SERUM ADIPOKINES AND ADIPOKINE RECEPTORS IN COLON CANCER PATIENTS WITH METABOLOC SYNDROM
by: N. V. Yunusova, et al.
Published: (2016-02-01)

61 Warfarin and GLP-1 Receptor Agonist Interaction Effects on Time in Therapeutic Range
by: Phillip Anjum, et al.
Published: (2025-05-01)

Dietary Recommendations for the Management of Gastrointestinal Symptoms in Patients Treated with GLP-1 Receptor Agonist
by: Gentinetta S, et al.
Published: (2024-12-01)

GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Game Charger in the Field?
by: Georgia Doumani, et al.
Published: (2024-11-01)

Effects of GLP‐1 Receptor Agonists on Paediatric Population in a Real World Setting
by: A. G. Barajas, et al.
Published: (2025-05-01)

Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning
by: Jung A Kim, et al.
Published: (2025-07-01)

GLP-1 receptor agonists and pulmonary hypertension in diabetes: A promising therapeutic strategy
by: Arif Albulushi, et al.
Published: (2025-07-01)

Evaluating GLP-1 receptor agonists versus metformin as first-line therapy for reducing dementia risk in type 2 diabetes
by: Xiaoling Wang, et al.
Published: (2025-07-01)

GABA and GLP-1 receptor agonist combination therapy modifies diabetes and Langerhans islet cytoarchitecture in a rat model of Wolfram syndrome
by: Toomas Jagomäe, et al.
Published: (2025-03-01)

Potential Roles of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in Nondiabetic Populations
by: Dan Xu, et al.
Published: (2022-01-01)

Predictors of Responsiveness to GLP-1 Receptor Agonists in Insulin-Treated Patients with Type 2 Diabetes
by: Colleen Gavigan, et al.
Published: (2023-01-01)

Endocrine and metabolic effects of GLP-1 receptor agonists on women with PCOS, a narrative review
by: Marine Monney, et al.
Published: (2025-03-01)

Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies
by: Héctor Iván Saldívar-Cerón, et al.
Published: (2025-06-01)

Pulmonary artery pressure trajectories in heart failure patients treated with GLP‐1 receptor agonists
by: Haoran Jiang, et al.
Published: (2025-08-01)

Can GLP-1 receptor agonists slow the progression of Autosomal Dominant Polycystic Kidney Disease?
by: Hamad Ali, et al.
Published: (2025-06-01)

The weight of choices: Prioritizing lifestyle over GLP-1 receptor agonist therapy in managing MASLD
by: Jörn M. Schattenberg, et al.
Published: (2025-07-01)

GLP-1 receptor agonists in Parkinson’s disease: an updated comprehensive systematic review with meta-analysis
by: Mohamed Mohsen Helal, et al.
Published: (2025-08-01)

The Expanding Role of GLP-1 Receptor Agonists: Advancing Clinical Outcomes in Metabolic and Mental Health
by: Mohamad Al Qassab, et al.
Published: (2025-04-01)

GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks
by: Ioannis Ilias, et al.
Published: (2025-01-01)

GLP-1 receptor agonists induce loss of lean mass: so does caloric restriction
by: Angelo Capodici, et al.

WCN25-3765 Title: Acalculous Cholecystitis, A rare complication of GLP 1 Receptor Agonist (GLP1 RA) after kidney transplant
by: Harshil Fichadiya, et al.
Published: (2025-02-01)